Experienced in ABO Incompatibility

Astrid Bauschke

Leipziger Str. 44, 
Magdeburg, ST, DE 
Experienced in ABO Incompatibility
Leipziger Str. 44, 
Magdeburg, ST, DE 
OverviewLocationsClinical Research

Overview

Astrid Bauschke practices in Magdeburg, Germany. Ms. Bauschke is rated as an Experienced expert by MediFind in the treatment of ABO Incompatibility. Her top areas of expertise are Pilonidal Sinus Disease, Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

Her clinical research consists of co-authoring 38 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of ABO Incompatibility.

Gender
Female

Locations

Leipziger Str. 44, Magdeburg, ST 39120, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: May 09, 2025
Intervention Type: Device, Drug
Study Drug: Cisplatin-Gemcitabine
Study Phase: Phase 2/Phase 3
Prospective, Randomized, Controlled, Multi-centric, Phase III Study for the Early Identification of Low-risk Patients After Partial Liver Resection by the LiMAx-test
Prospective, Randomized, Controlled, Multi-centric, Phase III Study for the Early Identification of Low-risk Patients After Partial Liver Resection by the LiMAx-test
Enrollment Status: Completed
Publish Date: October 25, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

38 Total Publications

Primary small bowel malignancies
Primary small bowel malignancies
Journal: Chirurgie (Heidelberg, Germany)
Published: May 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bauschke's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile